BSG and breast carcinoma: The oncogenic potential of CD147 is largely attributed to its role in promoting breast cancer cell migration and invasion, primarily through the activation of the MAPK/ERK signaling pathway and the induction of epithelial–mesenchymal transition (EMT) [14].